Ischemic Stroke and Excellent Recovery After Administration of Intravenous Tissue Plasminogen Activator

Pediatric Neurology

Volumn 38, Issue 2, 2008, Pages 126-129

  Jain, Sejal V ^a   Morton, Lawrence D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSPHENYTOIN SODIUM; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LABORATORY TEST; LOADING DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEIZURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VITAL SIGN;

ADOLESCENT; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; PARALYSIS; PLASMINOGEN ACTIVATORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38149010536     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.10.006     Document Type: Article

References (15)

1. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: Thrombolytic therapy for acute ischemic stroke-Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 47 (1996) 835-839
2. Jordan L.C. Stroke in childhood. Neurologist 12 (2006) 94-102
3. Matta A.P., Galvao K.R., and Oliveira B.S. Cerebrovascular disorders in childhood: Etiology, clinical presentation, and neuroimaging findings in a case series study. Arq Neuropsiquiatr 64 (2006) 181-185
4. Kirton A.G., and DeVeber G. Therapeutic approaches and advances in pediatric stroke. Neuro Rx 3 (2006) 133-142
5. Lynch J.K., Hirtz D.G., DeVeber G., and Nelson K.B. Report of the National Institute of Neurological Disorders and Stroke Workshop on Perinatal and Childhood Stroke. Pediatrics 109 (2002) 116-123
6. Lynch J.K., Pavlakis S., and DeVeber G. Treatment and prevention of cerebrovascular disorders in children. Curr Treat Options Neurol 7 (2005) 469-480
7. Berthet K., Lavergne T., Cohen A., et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 31 (2000) 398-403
8. Horton S.C., and Bunch T.J. Patent foramen ovale and stroke. Mayo Clin Proc 79 (2004) 79-88
9. Calder K., Kokorowski P., Tran T., and Henderson S. Emergency department presentation of pediatric stroke. Pediatr Emerg Care 19 (2003) 320-328
10. Shellhaas R.A., Smith S.E., O'Tool E., Licht D.J., and Ichord R.N. Mimics of childhood stroke: Characteristics of a prospective cohort. Pediatrics 118 (2006) 704-709
11. Hunter J.V. New radiographic techniques to evaluate cerebrovascular disorders in children. Semin Pediatr Neurol 7 (2000) 261-277
12. DeVeber G. In pursuit of evidence-based treatments for paediatric stroke: The UK and Chest guidelines. Lancet Neurol 4 (2005) 432-436
13. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
14. Janjua N., Nasar A., Lynch J.K., and Qureshi A.I. Thrombolysis for ischemic stroke in children. Data from the nationwide inpatient sample. Stroke 6 (2007) 1850-1854
15. Carpenter J., Tsuchida T., and Lynch J.K. Treatment of arterial ischemic stroke in children. Expert Rev Neurother 7 (2007) 383-392